Keyword Search: Gene Ontology, PubMed or Web (Google)

PDB Keywords for 1MFF

(Keywords from the PDB file are used here. They may or may not correspond to GO term names).

• Cytokine|Macrophage|Inflammatory Response|Tautomerase [GO] [PubMed] [Google]

GO Keywords for 1MFF

(Here all GO term names are given that map directly to this particular structure).

• prostaglandin biosynthetic process [GO] [PubMed] [Google]
• positive regulation of protein phosphorylation [GO] [PubMed] [Google]
• immune system process [GO] [PubMed] [Google]
• positive regulation of adaptive immune response [GO] [PubMed] [Google]
• negative regulation of mature B cell apoptotic process [GO] [PubMed] [Google]
• dopachrome isomerase activity [GO] [PubMed] [Google]
• signaling receptor binding [GO] [PubMed] [Google]
• cytokine activity [GO] [PubMed] [Google]
• cytokine receptor binding [GO] [PubMed] [Google]
• extracellular region [GO] [PubMed] [Google]
• extracellular space [GO] [PubMed] [Google]
• nucleoplasm [GO] [PubMed] [Google]
• cytoplasm [GO] [PubMed] [Google]
• inflammatory response [GO] [PubMed] [Google]
• cell surface receptor signaling pathway [GO] [PubMed] [Google]
• cell aging [GO] [PubMed] [Google]
• cell proliferation [GO] [PubMed] [Google]
• cell surface [GO] [PubMed] [Google]
• negative regulation of gene expression [GO] [PubMed] [Google]
• positive regulation of protein kinase A signaling [GO] [PubMed] [Google]
• isomerase activity [GO] [PubMed] [Google]
• carboxylic acid metabolic process [GO] [PubMed] [Google]
• DNA damage response, signal transduction by p53 class mediator [GO] [PubMed] [Google]
• positive regulation of B cell proliferation [GO] [PubMed] [Google]
• positive regulation of lipopolysaccharide-mediated signaling pathway [GO] [PubMed] [Google]
• vesicle [GO] [PubMed] [Google]
• negative regulation of cellular protein metabolic process [GO] [PubMed] [Google]
• negative regulation of myeloid cell apoptotic process [GO] [PubMed] [Google]
• positive regulation of peptidyl-serine phosphorylation [GO] [PubMed] [Google]
• chemoattractant activity [GO] [PubMed] [Google]
• regulation of cell proliferation [GO] [PubMed] [Google]
• positive regulation of phosphorylation [GO] [PubMed] [Google]
• negative regulation of apoptotic process [GO] [PubMed] [Google]
• myelin sheath [GO] [PubMed] [Google]
• positive regulation of MAP kinase activity [GO] [PubMed] [Google]
• negative regulation of DNA damage response, signal transduction by p53 class mediator [GO] [PubMed] [Google]
• innate immune response [GO] [PubMed] [Google]
• positive regulation of fibroblast proliferation [GO] [PubMed] [Google]
• phenylpyruvate tautomerase activity [GO] [PubMed] [Google]
• positive regulation of cytokine secretion [GO] [PubMed] [Google]
• positive regulation of peptidyl-tyrosine phosphorylation [GO] [PubMed] [Google]
• positive chemotaxis [GO] [PubMed] [Google]
• positive regulation of prostaglandin secretion involved in immune response [GO] [PubMed] [Google]
• positive regulation of myeloid leukocyte cytokine production involved in immune response [GO] [PubMed] [Google]
• extracellular exosome [GO] [PubMed] [Google]
• protein homotrimerization [GO] [PubMed] [Google]
• positive regulation of ERK1 and ERK2 cascade [GO] [PubMed] [Google]
• negative regulation of cell cycle arrest [GO] [PubMed] [Google]
• positive regulation of arachidonic acid secretion [GO] [PubMed] [Google]
• negative regulation of cell aging [GO] [PubMed] [Google]
• negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO] [PubMed] [Google]
• positive regulation of chemokine (C-X-C motif) ligand 2 production [GO] [PubMed] [Google]